Latest news
REPL Stock Hits Near 18-Month High On Pricing Of $150M Offering – But, Retail Sees Share Price ‘Unwinding Over Time’ - tradingview.comtradingview.com · Mon, 10 Aug 2026 16:21:20 GMTCan Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval? - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 12:42:42 GMT1st mRNA flu vaccine gets FDA nod after rare U-turn. What the technology does & why it faced scrutiny - ThePrintThePrint · Mon, 10 Aug 2026 10:41:07 GMTSpectral Medical (TSX:EDT) Files for FDA Approval After Sepsis Trial Delivers a Rare Survival Win - kalkine.cakalkine.ca · Mon, 10 Aug 2026 10:09:00 GMTFreenome (FRNM) Following FDA Approval Why Its 36.8x P S Still Looks Pricey - simplywall.stsimplywall.st · Mon, 10 Aug 2026 03:35:44 GMTWhy uniQure (QURE) Is Up 6.4% After FDA Alignment On Accelerated AMT-130 Approval Path - simplywall.stsimplywall.st · Sun, 09 Aug 2026 19:35:10 GMTReplimune in the spotlight: Earnings loom days after FDA approval By Investing.com - Investing.com UKInvesting.com UK · Sun, 09 Aug 2026 18:01:18 GMTOncologists Discuss Accelerated FDA Approvals and Surrogate Endpoints After Zepzelca Withdrawal - OncodailyOncodaily · Sun, 09 Aug 2026 16:07:14 GMT